C57BL/6 Congenic Mouse NRAS(Q61K) Melanoma Cell Lines are Highly Sensitive to the Combination of MEK and AKT Inhibitors In Vitro and In Vivo

Raymond J. H.

首页> 外文期刊>The Journal of investigative dermatology. >C57BL/6 Congenic Mouse NRAS(Q61K) Melanoma Cell Lines are Highly Sensitive to the Combination of MEK and AKT Inhibitors In Vitro and In Vivo

【24h】

C57BL/6 Congenic Mouse NRAS(Q61K) Melanoma Cell Lines are Highly Sensitive to the Combination of MEK and AKT Inhibitors In Vitro and In Vivo

机译：C57BL / 6 Congenic Mouse NRAS（Q61K）黑素瘤细胞系对MEK和AKT抑制剂的组合高度敏感，体外和体内

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Journal of investigative dermatology.》 |2019年第2期|共1页
作者
Raymond J. H.;
展开▼
作者单位

Inst Curie Normal &

Pathol Dev Melanocytes Orsay France;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类皮肤病学与性病学;
关键词

相似文献

外文文献
中文文献
专利

1. C57BL/6 Congenic Mouse NRAS(Q61K) Melanoma Cell Lines are Highly Sensitive to the Combination of MEK and AKT Inhibitors In Vitro and In Vivo [J] . Raymond J. H. The Journal of investigative dermatology. . 2019,第9Suppla2期

机译：C57BL / 6 Congenic Mouse NRAS（Q61K）黑素瘤细胞系对MEK和AKT抑制剂的组合高度敏感，体外和体内
2. Transcriptome of melanoma cells from two mouse models, Tyr:NRas Q61K and Tyr:Rack1-HA, Tyr:NRas Q61K [J] . Cécil Campagne, Stéphanie Pons, Diane Esquerre, Data in Brief . 2017,第1期

机译：来自两种小鼠模型的黑素瘤细胞的转录组， Tyr：NRas Q61K 和 Tyr：Rack1-HA，Tyr：NRas Q61K
3. Synergistic effects of eIF4A and MEK inhibitors on proliferation of NRAS-mutant melanoma cell lines [J] . Malka-Mahieu Helene, Girault Isabelle, Rubington Margot, Cell cycle . 2016,第18期

机译：eIF4A和MEK抑制剂对NRAS突变型黑色素瘤细胞株增殖的协同作用
4. Combination of 8-methoxypsoralen and ultraviolet A inhibits smooth muscle proliferation in vitro and in vivo after angioplasty [C] . Keith L. March, Indiana Univ. School of Medicine, Indianapolis, Diagnostic and Therapeutic Cardiovascular Interventions IV . 1994

机译：8-甲氧基补骨脂素与紫外线A的组合在血管成形术后体外和体内抑制平滑肌增殖
5. Optimizing MEK Inhibitors in NRAS Mutant Melanoma - Overcoming Resistance and Combination Strategies [D] . Nguyen, Mai. 2021

机译：优化NRAS突变体黑素瘤耐久性和组合策略中的MEK抑制剂
6. Combined targeting of MEK and PI3K/mTOR effector pathways is necessary to effectively inhibit NRAS mutant melanoma in vitro and in vivo [O] . Christian Posch, Homayoun Moslehi, Luzviminda Feeney, 2013

机译：联合靶向MEK和PI3K / mTOR效应子途径对于有效抑制NRAS突变型黑色素瘤在体外和体内是必要的
7. Transcriptome of melanoma cells from two mouse models, Tyr:NRas Q61K and Tyr:Rack1-HA, Tyr:NRas Q61K [O] . Campagne, Cécil, Pons, Stéphanie, Esquerre, Diane, 2017

机译：来自两种小鼠模型的Tyr：NRas Q61K和Tyr：Rack1-HA，Tyr：NRas Q61K的黑色素瘤细胞的转录组

C57BL/6 Congenic Mouse NRAS(Q61K) Melanoma Cell Lines are Highly Sensitive to the Combination of MEK and AKT Inhibitors In Vitro and In Vivo

著录项

相似文献

相关主题

期刊订阅